©1996-2017 All Rights
Reserved. Online Journal of Veterinary Research.
You may not store these pages in any form except for your own personal use. All
other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the
before mentioned must be gained in writing from the publisher. This
article is exclusively copyrighted in its entirety to OJVR publications. This
article may be copied once but may not be, reproduced or re-transmitted without
the express permission of the editors.
OJVRTM®
Online Journal of Veterinary Research©
Volume 4:99-105 1999
Immunogenicity of influenza glycoproteins with
different forms of supramolecular organization in hens
A P Bogoyavlenskiy, V E Berezin, V P Tolmacheva, S S Khudyakova, A V Ogneva
Laboratory of Antivirus Protection, Institute of Microbiology &
Virology, Almaty, Kazakhstan, Address for correspondence A.P. Bogoyavlenskiy: Laboratory of Antivirus Protection,
Institute of Microbiology & Virology, Almaty, Kazakhstan.
ABSTRACT
Bogoyavlenskiy AP, Berezin VE, Tolmacheva VP, Khudyakova SS, Ogneva AV., Immunogenicity of influenza glycoproteins with different
forms of supramolecular organization in hens, Online J Vet Res, 4:99-105, 1999. The immunogenicity of an influenza A subunit vaccine preparation administered to
hens in glycoprotein micelles, complex of glycoproteins with glycoside Quil A, and glycoproteins mixed with complete Freund's
adjuvant were assessed in comparative studies with formalinized whole virus.
The results showed that immunization of the influenza antigen preparations
induced variable levels of antibodies at 14, 21, 35, 77, 98 and 300 days
post-immunization. Immune Stimulating complexes (ISCOMs) were the most
efficient antigen formulation of purified FPV glycoproteins stimulating a
higher level of humoral immunity than whole virus or glycoprotein micelles.
ISCOMs also stimulated a high level of antibodies in egg-yolk. Egg-yolk
antibody titers were correlated with the level of serum antibodies.
KEYWORDS:
humoral immunity, influenza vaccines, ISCOMs